Expertise in
4
conditions

Daniel Windschall

Halle, NI, DE 
Expertise in
4
conditions
Halle, NI, DE 

Overview

Daniel Windschall practices practicing medicine in Halle, Germany.

Mr. Windschall is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Juvenile Idiopathic Arthritis (JIA), Synovitis, Arthritis, and Tenosynovitis.

He is actively involved in clinical research, co-authoring 49 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Halle, NI, Germany
Other Locations
St. Josef Stift Sendenhorst, Sendenhort, Stift, SH, Germany
St. Josef Stift, Sendenhorst, NW, Germany
Weissenfels, ST 06667, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Multicenter, Open-label, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of Subcutaneous Ixekizumab With Adalimumab Reference Arm, in Children With Juvenile Idiopathic Arthritis Subtypes of Enthesitis-related Arthritis (Including Juvenile-Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: August 12, 2026
Intervention Type: Drug
Study Drugs: Ixekizumab, Adalimumab
Study Phase: Phase 3

49 Total Publications

Janus kinase inhibitors are of limited use in refractory JIA-associated uveitis: retrospective data from a tertiary uveitis center.
Janus kinase inhibitors are of limited use in refractory JIA-associated uveitis: retrospective data from a tertiary uveitis center.
Journal: Pediatric rheumatology online journal
Published: April 01, 2026

Frequently Asked Questions about Daniel Windschall

Is Daniel Windschall a top-rated expert for Juvenile Idiopathic Arthritis (JIA)?

MediFind is an objective health platform that identifies experts based on real-world data. Daniel Windschall is classified as an Elite expert for Juvenile Idiopathic Arthritis (JIA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniel Windschall participate in research or clinical trials?

Yes. Daniel Windschall has published 49 articles and abstracts on conditions like Juvenile Idiopathic Arthritis (JIA). You can view a list of Daniel Windschall's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Windschall's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile